CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2018		Dec. 31, 2017
Cash and cash equivalents	$ 580		$ 390
Accounts receivable—trade, net	1,093		328
Accounts receivable—other	252		42
Contracts in progress	723	[1]	621
Other current assets	145		36
Accounts payable	874		279
Advance billings on contracts	1,733	[1]	32
Accrued liabilities, current	$ 1,579		$ 372
Common stock, par value	$ 1.00		$ 1.00
Common stock, shares authorized	255,000,000		255,000,000
Common stock, shares issued	183,000,000		98,000,000
Treasury stock, shares	3,000,000		3,000,000
Variable Interest Entities ("VIEs") [Member]
Cash and cash equivalents	$ 158		$ 0
Accounts receivable—trade, net	28		0
Accounts receivable—other	59		0
Contracts in progress	63		0
Other current assets	26		0
Accounts payable	328		0
Advance billings on contracts	476		0
Accrued liabilities, current	$ 110		$ 0

[1] Costs incurred in excess of costs recognized (assets) and costs recognized in excess of costs incurred (liabilities) resulted from the exclusion of certain costs when measuring progress toward completion under the cost-to-cost method, prior to our adoption of ASC Topic 606. These remaining amounts will be recognized in Cost of operations as the underlying projects progress.